These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 17714093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N, Salem A, Irvine RJ.
    Neuroscience; 2007 Apr 25; 146(1):321-9. PubMed ID: 17306465
    [Abstract] [Full Text] [Related]

  • 4. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E, Summavielle T, Alves CJ, Custódio JB, Fernandes E, de Lourdes Bastos M, Tavares MA, Carvalho F.
    Addict Biol; 2009 Apr 25; 14(2):185-93. PubMed ID: 19076925
    [Abstract] [Full Text] [Related]

  • 5. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD, Owens WA, Javors MA, Sanchez TA, Jones DJ, Irvine RJ, Daws LC.
    J Neurochem; 2007 Feb 25; 100(3):617-27. PubMed ID: 17181558
    [Abstract] [Full Text] [Related]

  • 6. 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis.
    Matsumoto T, Maeno Y, Kato H, Seko-Nakamura Y, Monma-Ohtaki J, Ishiba A, Nagao M, Aoki Y.
    Eur Neuropsychopharmacol; 2014 Aug 25; 24(8):1362-70. PubMed ID: 24862256
    [Abstract] [Full Text] [Related]

  • 7. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 25; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 8. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR.
    Br J Pharmacol; 1997 Jun 25; 121(4):827-33. PubMed ID: 9208155
    [Abstract] [Full Text] [Related]

  • 9. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R, Kerans A, O'Neill B, Harkin A.
    Neuropharmacology; 2006 Jan 25; 50(1):69-80. PubMed ID: 16188283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
    Bankson MG, Yamamoto BK.
    J Neurochem; 2004 Nov 25; 91(4):852-9. PubMed ID: 15525339
    [Abstract] [Full Text] [Related]

  • 12. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE, Nichols DE.
    J Pharmacol Exp Ther; 1995 May 25; 273(2):667-73. PubMed ID: 7538579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
    Callaghan PD, Irvine RJ, Daws LC.
    Neurochem Int; 2005 Oct 25; 47(5):350-61. PubMed ID: 15979209
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul 25; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 16. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY.
    Synapse; 1999 Mar 01; 31(3):169-77. PubMed ID: 10029234
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 01; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 19. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Ann N Y Acad Sci; 2004 Oct 01; 1025():189-97. PubMed ID: 15542717
    [Abstract] [Full Text] [Related]

  • 20. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
    Iravani MM, Asari D, Patel J, Wieczorek WJ, Kruk ZL.
    Synapse; 2000 Jun 15; 36(4):275-85. PubMed ID: 10819905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.